
Poonawalla Biotech Private Limited
About Poonawalla Biotech Private Limited
Data last updated:
Poonawalla Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231PN2005PTC021529.
The company has an authorised share capital of ₹5.6 Cr and a paid-up capital of ₹5.48 Cr. It is led by directors including Dattatraya Narayan Dhavalikar and Firdaus Jal Dastoor.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Saroshbhavan 16 – B/1 Drambedkarroad, Pune, Maharashtra, India – 411001.
As per the financials filed for FY 2025, the company reported a revenue of ₹44,250. For the same year it recorded a net loss of ₹19 Lakh and EBITDA of -₹19.63 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Poonawalla Biotech Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressSaroshbhavan 16 – B/1 Drambedkarroad, Pune, Maharashtra, India – 411001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Poonawalla Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Poonawalla Biotech Private Limited
FY 2025 filings availablePoonawalla Biotech Private Limited reported revenue of ₹44,250 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹19.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Poonawalla Biotech Private Limited, buy the company report.
Board of directors of Poonawalla Biotech Private Limited
Poonawalla Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dattatraya Narayan Dhavalikar Also directs: Andaman Finance and Investment Pvt Ltd, Magic-Square Hospitality Services LLP, Serene Productions LLP and 5 more | Director | 26 Dec 2014 | 11 Years 10 Months | Current |
| Firdaus Jal Dastoor Also directs: Serum Institute Life Sciences Private Limited, Pluto Real Estate Developers LLP, Ruby Real Estate Developers LLP and 5 more | Director | 03 Feb 2017 | 9 Years 9 Months | Current |
| Makarand Shrikrishna Karkare Also directs: Adrus Estates and Properties LLP, Vardhan Strategy Consultants LLP, Sovereign Pharma Private Limited and 5 more | Director | 11 Nov 2005 | 20 Years 11 Months | Current |
Peer comparison
Poonawalla Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Biotechnology industry (Biotechnology, Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anant Aayurved Anusandhan Private Limited | ₹45,583 (FY 2025) | Delhi, India | ||||
| Fagris Medica Private Limieted | ₹45,181 (FY 2020) | -95.0% | Navi Mumbai, Maharashtra, India | |||
| Pharma Fine Chemical Industries Private Limited | ₹44,915 (FY 2024) | 10.0% | Begusarai, Bihar, India | |||
| Tusya Ayurvedic Private Limited | ₹44,625 (FY 2022) | Mumbai, Maharashtra, India | ||||
| Zion Biotechnologies Private Limited | ₹44,520 (FY 2025) | 6.0% | Delhi, India | |||
| Poonawalla Biotech Private Limitedthis company | ₹44,250 (FY 2025) | -₹19 Lakh | Pune, Maharashtra, India | |||
| Genophe Biotech Private Limited | ₹44,240 (FY 2024) | -97.0% | Bangalore, Karnataka, India | |||
| Goodhealth Holdings Private Limited | ₹44,000 (FY 2025) | Chennai, Tamil Nadu, India | ||||
| Ultimed Pharma Private Limited | ₹43,503 (FY 2021) | -92.0% | Mumbai, Maharashtra, India | |||
| DBS Pharma Private Limited | ₹42,900 (FY 2024) | -100.0% | Hyderabad, Telangana, India | |||
| Alpa Expoim Private Limited | ₹42,390 (FY 2021) | New Delhi, Delhi, India |
To see the full peer comparison of Poonawalla Biotech Private Limited, buy the company report.
Auditor
Poonawalla Biotech Private Limited is audited by PATKI & SOMAN for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PATKI & SOMAN | FY 2021 | 107830W |
Shareholding
The shareholding of Poonawalla Biotech Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Poonawalla Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Poonawalla Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Poonawalla Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Poonawalla Biotech has 1 associated company. This group structure data is as of FY 2021. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Poonawalla Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Poonawalla Biotech Private Limited has 6 board changes on record since 2005: 3 appointments and 3 cessations. The latest: Firdaus Jal Dastoor ceased to be Additional Director on 27 Sep 2017.
Frequently asked questions
Poonawalla Biotech is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 November 2005 (21+ years old) and is registered under CIN U24231PN2005PTC021529.
Poonawalla Biotech has 3 current directors:
- Dattatraya Narayan Dhavalikar - Director
- Firdaus Jal Dastoor - Director
- Makarand Shrikrishna Karkare - Director
The latest financial statements of Poonawalla Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Poonawalla Biotech is U24231PN2005PTC021529. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Poonawalla Biotech was incorporated on 11 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Poonawalla Biotech by revenue are Anant Aayurved Anusandhan Private Limited, Fagris Medica Private Limieted, Pharma Fine Chemical Industries Private Limited, Tusya Ayurvedic Private Limited, Zion Biotechnologies Private Limited and 5 more, all in the Biotechnology industry (Biotechnology, Formulations).
Firdaus Jal Dastoor ceased to be Additional Director on 27 Sep 2017. Firdaus Jal Dastoor was appointed as Director on 03 Feb 2017. Dattatraya Narayan Dhavalikar ceased to be Additional Director on 22 Sep 2015. Poonawalla Biotech has 6 board changes on record in total.
The registered office of Poonawalla Biotech is at Saroshbhavan 16 – B1 Drambedkarroad, Pune, Maharashtra, India – 411001.
Poonawalla Biotech operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Poonawalla Biotech is compliant as of 05 September 2026. The company is actively filing with the Registrar of Companies.
Poonawalla Biotech can be reached at its registered office: Saroshbhavan 16 – B1 Drambedkarroad, Pune, Maharashtra, India – 411001.

